glp-1 fatty liver disease and Your Liver: What to Monitor While on Semaglutide or Tirzepatide Why are GLP-1 agonists being

Most people tolerate these medications well, but some mild side effects are common as your body adjusts

Semaglutide and tirzepatide achieve approximately 15-20% body weight reduction in clinical trials

Improved Sleep : Poor sleep, especially from sleep apnea, can throw off hormone production

The common factors among this group include having established strong exercise habits during treatment (particularly resistance training), having completely overhauled eating patterns with a focus on high-protein whole-food diets, gradual tapering rather than abrupt discontinuation, and having lost weight slowly enough for metabolic adaptation to partially recalibrate

In the HepG2 fatty liver cell model, hypoxia-inducible factor-2alpha (HIF-2)/PPAR pathway was found to be essential for Lira to inhibit liver lipid synthesis and reduce lipid-induced hepatic steatosis [57]